INTRODUCTION
============

Establishing embryonic stem cells (ESCs) in domestic animals aids in the understanding of embryonic biology and improves the outcomes of regenerative medicine studies using stem cells. The pig is an ideal animal model for biomedical research, as it is immunologically and physiologically similar to humans. The pig has potential for xenografting and cell therapy regenerative medicine studies ([@b25-ajas-28-11-1565]). Thus, numerous efforts have been made to establish pluripotent stem cells from porcine embryos. Although authentic porcine embryonic stem cell (pESC) lines have not been derived, a number of putative pESCs have been established from various porcine embryos, including *in vitro*-produced and *in vivo*-derived embryos and parthenogenetic embryos, as well as *in vitro*-aggregated and somatic cell nuclear transfer (SCNT) embryos ([@b17-ajas-28-11-1565]; [@b14-ajas-28-11-1565]; [@b27-ajas-28-11-1565]; [@b22-ajas-28-11-1565]). However, most of these showed limited pluripotency compared with that of mouse embryonic stem cells (mESCs). In particular, these putative pESCs do not form teratomas or display germ-line chimerism.

We previously conducted a comparative study of stem cells reprogrammed in pigs using epiblast stem cell (EpiSC)-like pESC lines derived from porcine embryos of various origins, including *in vitro* fertilized (IVF), *in vivo*-derived, IVF-aggregated, and parthenogenetic embryos ([@b22-ajas-28-11-1565]). These previous results showed that stem cell lines derived from porcine pre-implantation embryos from various origins exhibited flattened morphology and had the ability to differentiate *in vitro* and to activate the fibroblast growth factor and nodal/activin pathways. They belong to the primed state, rather than the naïve state, cell category. Alberio et al. reported a porcine EpiSC line from embryonic day 10.5 to 12 porcine embryos that activated nodal/activin signaling to maintain their pluripotency ([@b2-ajas-28-11-1565]). Thus, putative pESCs are similar to porcine EpiSCs but different from mESCs with respect to morphology and the pathways activated.

In humans as well as in pigs, *in vitro* culture conditions are suboptimal and result in low blastocyst rates or blastocysts with low cell numbers and a lack of a distinct inner cell mass (ICM) ([@b24-ajas-28-11-1565]). IVF embryos show less developmental competence and poorer ICM quality than do *in vivo*-produced embryos ([@b3-ajas-28-11-1565]). Embryo quality also affects the efficiency of ESC derivation because ESCs are derived from the ICM ([@b12-ajas-28-11-1565]). An embryo aggregation technique has been used to improve the quality of IVF embryos. Early embryo aggregation studies produced transgenic chimeras in mice ([@b20-ajas-28-11-1565]; [@b28-ajas-28-11-1565]) and cattle ([@b4-ajas-28-11-1565]; [@b5-ajas-28-11-1565]). Subsequent studies demonstrated the advantages of aggregation to enhance *in vitro* development ([@b26-ajas-28-11-1565]) as a means of rescuing cell blocks ([@b21-ajas-28-11-1565]) and overcoming early developmental obstacles in cloning by SCNT ([@b6-ajas-28-11-1565]). Our previous study demonstrated that aggregating porcine IVF embryos increased the *in vitro* development rate and total cell numbers, with a proportional increase in both ICM and trophectoderm (TE) cells and expression of mRNAs related to embryo quality ([@b16-ajas-28-11-1565]).

Therefore, the present study evaluated whether these blastocysts could be used to derive pESCs and assessed the effects of deriving pES-like cells from IVF-aggregated blastocysts. The results showed that our cell lines expressed pluripotent markers, had normal karyotypes, and retained the potential to differentiate into the three germ layers under *in vitro* conditions. We demonstrated that embryo aggregation is an efficient technique to overcome the obstacles produced by *in vitro* methods and that the techniques can be used to study early development and derive authentic pluripotent pESCs.

MATERIALS AND METHODS
=====================

Animal welfare
--------------

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals. The care and experimental use of pigs and mice was approved by the Institute of Laboratory Animal Resources, Seoul National University (SNU-140217--3).

Embryo aggregation and *in vitro* culture
-----------------------------------------

Oocytes and IVF embryos were produced using the method described in our previous study ([@b16-ajas-28-11-1565]). After IVF for 2 days, the zona pellucida of four-cell-stage embryos was removed with acidic Tyrode's solution (Sigma-Aldrich, St. Louis, MO, USA; <http://www.sigmaaldrich.com>). Clusters of depressions were generated in the bottom of a culture dish using gentle pressure with a darning needle (BLS, Budapest, Hungary <http://www.bls-ltd.com>) and were covered with microdrops (40 μL) of North Carolina State University-23 medium supplemented with 4 mg/mL fatty acid-free bovine serum albumin (Sigma-Aldrich, USA) ([@b23-ajas-28-11-1565]), overlaid with oil, and incubated for at least 1 h prior to use. Zona-free embryos were placed in groups of two or three into each microwell for aggregation. Non-aggregated (1×), two-embryo aggregated (2×), and three-embryo aggregated (3×) four-cell-stage embryos were cultured in parallel in separate drops within the same dish. The aggregates were cultured at 39°C in a 5% CO~2~, 5% O~2~, and 90% N~2~ atmosphere for 2 days and then added to microwells containing 10% fetal bovine serum (FBS; collected and processed in Canada; Hyclone, Logan, UT, USA; [www.hyclone.com](www.hyclone.com)) ([@b13-ajas-28-11-1565]).

Derivation of outgrowths from porcine blastocysts
-------------------------------------------------

Porcine blastocysts were cultured on mitotically inactivated mouse embryonic fibroblasts (MEFs) in pESC medium, which was a 50:50 mixture of low-glucose Dulbecco's modified Eagle's medium (Gibco/Invitrogen, Carlsbad, CA, USA; [www.invitrogen.com](www.invitrogen.com)) and Ham's F10 medium (Gibco), supplemented with 15% FBS, 2 mM Glutamax (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 1× Minimum Essential Medium with nonessential amino acids (Gibco), 1× antibiotic/antimycotic (Gibco) containing cytokines, 40 ng/mL human recombinant stem cell factor (R&D Systems, Minneapolis, MN, USA; [www.rndsystems.com](www.rndsystems.com)), and 20 ng/mL human recombinant basic fibroblast growth factor (R&D Systems, USA). Two seeding methods were used to establish the pluripotent cell lines: intact blastocyst-stage embryos either were cultured directly on MEFs or were subjected to mechanical dissection under a microscope using pulled glass pipettes to separate the ICM from the TE prior to seeding. ES-like primary colonies derived from day 7 *in vivo*-produced and day 8 *in vitro*-hatched blastocysts were observed after 5 to 7 days of culture. These ES-like cell colonies were mechanically dissociated into several clumps using pulled glass pipettes 10 to 15 days after seeding. The dissociated clumps were re-seeded on fresh inactivated MEFs, and the subsequent ES-like cell lines were routinely passaged via the pulled glass pipette method every 5 to 7 days. All cells were cultured under humidified conditions at 37°C with 5% CO~2~.

Alkaline phosphatase activity and immunocytochemistry analyses
--------------------------------------------------------------

For alkaline phosphatase (AP) staining, the cells were fixed in 4% paraformaldehyde for 15 min. After washing, the fixed cells were stained with a solution containing a nitro blue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate toluidine salt stock solution (Roche, Madison, WI, USA; [www.roche.com](www.roche.com)) in a buffer solution for 30 min at room temperature. The fixed cells were washed and permeabilized (for intracellular markers only) with 0.2% Triton X-100 (Sigma, USA) for 5 min for the immunocytochemistry (ICC) analysis of undifferentiated or differentiated cells. The washed cells were co-incubated with blocking solution (10% goat serum in Dulbecco's phosphate-buffered saline) and primary antibodies overnight at 4°C. The primary antibodies used were Oct4 (SC-9081, Santa Cruz Biotechnology, Santa Cruz, CA, USA; [www.scbt.com](www.scbt.com) 1:100), Nanog (SC-33759, Santa Cruz Biotechnology, USA, 1:100), Sox2 (AB5603, Millipore, Temecula, CA, USA; [www.millipore.com](www.millipore.com), 1:200), neurofilament (MAB1615, Millipore, USA, 1:200), vimentin (MAB3400, Millipore, USA, 1:200), and cytokeratin17 (MAB1625, Millipore, USA, 1:200). The cells were washed, incubated with the appropriate secondary antibody, and stained with Hoechst 33342 or propidium iodide. The stained cells were examined under a confocal microscope using ZEN 2012 Light Edition (Carl Zeiss, Zena, Germany; [www.zeiss.com](www.zeiss.com)).

Embryoid body formation and *in vitro* differentiation
------------------------------------------------------

The ES-like cell lines were removed from MEFs, mechanically dissociated with glass pipettes, and cultured in pESC medium without cytokines using the hanging drop method to evaluate differentiation potential. ES-like cells forming typical embryoid bodies (EBs) after 5 days were transferred to confocal dishes coated with 0.1% gelatin and allowed to further differentiate for 2 to 3 weeks.

Reverse transcriptase-polymerase chain reaction analysis
--------------------------------------------------------

Total RNA from individual samples was extracted using TRIZOL reagent (Invitrogen, USA) according to the manufacturer's instructions to analyze the gene expression patterns of undifferentiated and differentiated cells. cDNA was synthesized using a High Capacity RNA-to-cDNA Kit (Applied Biosystems, Foster City, CA, USA; [www.appliedbiosystems.com](www.appliedbiosystems.com)) according to the manufacturer's instructions, producing a final volume of 20 μL. Polymerase chain reaction (PCR) amplifications were performed using the 2× PCR Master Mix Solution (i-MAX II, iNtRON Biotechnology, Daejeon, Korea; <http://eng.intronbio.com/>) in a total reaction volume of 20 μL, containing 1 μL cDNA, 1 μL of each primer, and 7 μL distilled water. The conditions and primers used are listed in [Table 1](#t1-ajas-28-11-1565){ref-type="table"}.

Karyotyping
-----------

Standard G-banding chromosome and cytogenetic analyses were carried out at Samkwang Medical Laboratories (Seoul, Korea; [www.smlab.co.kr](www.smlab.co.kr)).

Statistical analysis
--------------------

The statistical analysis was performed using the "R" program (<http://www.R-project.org>). Aggregated embryo development to the blastocyst stage was analyzed using the two-tailed Fisher's exact test. Treatment differences were considered significant when the p-value was \<0.05.

RESULTS
=======

Outgrowths derived from porcine blastocysts
-------------------------------------------

We observed blastocyst surface morphology and blastocysts attaching onto the feeder cell layer under high magnification to identify the early outgrowth process in porcine blastocysts. As shown in [Figure 1A](#f1-ajas-28-11-1565){ref-type="fig"} and [1B](#f1-ajas-28-11-1565){ref-type="fig"}, giant cells were observed on the surface section of the blastocysts, which were the so-called TE. A mass of cells, the so-called ICM, was present inside the blastocysts. The cells in the ICM were smaller than those of the TE. The giant cells shown in [Figure 1C](#f1-ajas-28-11-1565){ref-type="fig"} initially proliferated 3 days after seeding the blastocysts and then gradually died out or disappeared within a few days, except the mass of cells presumed to be the ICM ([Figure 1C](#f1-ajas-28-11-1565){ref-type="fig"} and [1D](#f1-ajas-28-11-1565){ref-type="fig"}). We observed small primary colonies with a compact multi-layer morphology after about 7 days ([Figure 1E](#f1-ajas-28-11-1565){ref-type="fig"}). However, the multi-layer morphology changed to mono-layer morphology after 3 to 4 days. Outgrowths were passaged onto a new feeder layer about 14 days after seeding ([Figure 1F](#f1-ajas-28-11-1565){ref-type="fig"}). We passaged the cell lines every 5 days. We have been able to establish ES-like cell lines from various embryos, such as *in vivo*-derived, IVF, and IVF-aggregated (3×) blastocysts, using these methods. The efficiencies of all established cell lines are summarized in [Table 2](#t2-ajas-28-11-1565){ref-type="table"}. We confirmed similar primary colony morphology and a typical morphology among these cell lines.

Effect of embryo aggregation on deriving pES-like cells from *in vitro* fertilized blastocysts
----------------------------------------------------------------------------------------------

Non-aggregated (1×) and aggregated (2× and 3×) blastocysts were produced in parallel in separate drops under the same conditions while we were determining the effects of embryo aggregation on deriving outgrowths from IVF blastocysts. The total numbers of aggregated embryos that developed to the 1×, 2×, and 3× blastocyst stages are shown in [Table 3](#t3-ajas-28-11-1565){ref-type="table"}. The aggregation rates of the 2× and 3× aggregates were not different (78.4% for 2× vs 84.8% for 3×) 24 h after aggregation. However, development to the blastocyst stage increased significantly in the aggregated embryos (82.8% for 2× and 84.5% for 3×) compared with that of the non-aggregated embryos (46.8% for 1×) (p\< 0.05). Moreover, the morphology of the 2× and 3× aggregated blastocysts was superior to that of non-aggregated blastocysts ([Figure 2](#f2-ajas-28-11-1565){ref-type="fig"}). When non-aggregated and aggregated embryos were seeded onto a feeder layer, the rate of blastocyst attachment was similar between the non-aggregated and aggregated blastocysts of each group (70% to 80%; data not shown). As shown in [Table 2](#t2-ajas-28-11-1565){ref-type="table"}, more cell lines were derived from the 3× aggregate group (9.4%) than from the single embryo group (5%).

Verification of undifferentiated state and differentiation potential from outgrowths
------------------------------------------------------------------------------------

We investigated pluripotent marker expression in all cell lines. As shown [Figure 3A](#f3-ajas-28-11-1565){ref-type="fig"}, all cell lines expressed the Oct4, Sox2, and Nanog pluripotent marker genes, which play crucial roles as transcription factors in mESCs ([@b7-ajas-28-11-1565]; [@b18-ajas-28-11-1565]). Our cell lines showed similar primary colony morphology and typical morphology and AP activity ([Figure 3B](#f3-ajas-28-11-1565){ref-type="fig"}). As shown in [Figure 3C](#f3-ajas-28-11-1565){ref-type="fig"}, we confirmed Oct4, Sox2, and Nanog expression in our cell lines by ICC analysis. We investigated EB formation and differentiation capacity into the three germ layers, such as endoderm, mesoderm, and ectoderm. As shown in [Figure 4A](#f4-ajas-28-11-1565){ref-type="fig"} and [4B](#f4-ajas-28-11-1565){ref-type="fig"}, the cell lines demonstrated normal karyotypes and the potential to form EBs when induced to differentiate after 5 days of culture using the hanging drop method. We observed a variety of differentiated cells after 1 to 2 weeks, when EBs were cultured on plates coated with 0.1% gelatin. As shown in [Figure 4C to 4E](#f4-ajas-28-11-1565){ref-type="fig"}, we confirmed the expression of three germ layer markers, including cytokeratin17 (endoderm), vimentin (mesoderm), and neurofilament (ectoderm) from differentiated cells in the ICC analysis. Nanog was not expressed in differentiated cells. These results indicate that the cell lines possess self-renewal and differentiation potential.

DISCUSSION
==========

Blastocysts comprise two cell populations during embryogenesis ([@b11-ajas-28-11-1565]). The first is the ICM, which subsequently develops into the epiblast and hypoblast; the epiblast forms the fetus. Therefore, the epiblast is referred to as a pluripotent cell population due to its capacity to generate all lineages, and it has been utilized as an ESC source. The other is the TE, which exists in an outer layer of blastocyst cells and gives rise to the fetal placenta. We observed the early process of generating ESCs from porcine embryos to understand the process of establishing ESC lines from porcine embryos. As shown in [Figure 1A](#f1-ajas-28-11-1565){ref-type="fig"} and [1B](#f1-ajas-28-11-1565){ref-type="fig"}, we observed two cell types in porcine blastocysts under high magnification; giant cells were found in the outer layer of the TE, and an ICM-like small cell mass existed on the interior of blastocysts. These two cell types were observed on the feeder cell layer 2 to 3 days after seeding the blastocysts ([Figure 1C](#f1-ajas-28-11-1565){ref-type="fig"} and [1D](#f1-ajas-28-11-1565){ref-type="fig"}). However, the presumptive TE cells disappeared gradually, and ES-like primary cells were seen on the feeder cells about 7 days after seeding the embryos. As in our previous report ([@b22-ajas-28-11-1565]), we observed mouse ES-like colonies with a compact and dome-shape morphology at the early primary colony stage. However, the dome-shape morphology of the early primary colonies tended to differentiate into epithelial-like cells with a flat morphology after 2 to 3 days ([Figure 1E](#f1-ajas-28-11-1565){ref-type="fig"} and [1F](#f1-ajas-28-11-1565){ref-type="fig"}). These flat ES-like cells were stably maintained for a long period without losing stemness or self-renewal potential. Further studies on optimal culture conditions to suppress differentiation into the primed state from the naïve pluripotent state are needed to establish authentic pESCs.

A remaining question is why it is more difficult to derive ESCs from other than *in vivo*-produced embryos. We hypothesized that the competence of the starting material affects poor derivation of pESCs. The embryo aggregation technique was applied to overcome the suboptimal pig embryo culture conditions. Aggregation of four-cell-stage porcine embryos efficiently supported *in vitro* blastocyst development, which resulted in a greater number of ES-like cell colonies formed than in non-aggregated blastocysts under the same culture conditions.

When aggregation occurs before the cell lineage forms, cells from each embryo can contribute to all cell lineages of the resulting embryos ([@b19-ajas-28-11-1565]). Interactions between these cells are more prominent; thus, these cells are more likely to be involved in complementation ([@b5-ajas-28-11-1565]; [@b10-ajas-28-11-1565]). One way to achieve complementation is through cell-to-cell communication, such as gap or tight junctions, and another is through non-cell autonomous factors, such as trophic factors that stimulate signaling in neighboring cells ([@b30-ajas-28-11-1565]). Therefore, complementation via intercellular signaling between aggregated embryos can affect *in vitro* development. In our previous report ([@b16-ajas-28-11-1565]), the four-cell stage was the best stage for aggregation in pigs. Moreover, aggregating IVF embryos enhances *in vitro* development at the pre-implantation stage. Similar results have been obtained after aggregating bovine cloned embryos at the four-cell stage ([@b30-ajas-28-11-1565]).

If aggregation of four-cell-stage embryos enhances *in vitro* development at the pre-implantation stage, it could influence isolation of ESCs derived from *in vitro*-produced blastocysts. Blastocyst quality is a very important factor when isolating ESCs for subsequent colony formation. Although porcine blastocysts have been obtained successfully using IVF and SCNT ([@b1-ajas-28-11-1565]; [@b15-ajas-28-11-1565]), their quality remains lower than that of *in vivo*-produced blastocysts. Obtaining a total cell number similar to that of *in vivo*-derived blastocysts is a valuable indicator of the viability of *in vitro-*produced embryos ([@b9-ajas-28-11-1565]). The total cell numbers of *in vivo*-derived blastocysts on days 6 and 7 were reported to be about 57 ([@b29-ajas-28-11-1565]), and 93 ([@b9-ajas-28-11-1565]), respectively, which increased to approximately 175 just before hatch ([@b8-ajas-28-11-1565]). Our previous report ([@b16-ajas-28-11-1565]) demonstrated that aggregation of four-cell-stage porcine embryos increased the number of cells with a normal ratio of ICM cells to total cells. The average mean cell numbers of 2× and 3× aggregated blastocysts were 129 and 169, respectively. The 3× aggregated embryos appeared to have similar numbers to those of blastocysts derived *in vivo* just before hatch, and even exceeded the number of cells in *in vivo*-derived blastocysts on day 7. Deriving outgrowth lines from *in vitro*-produced embryos can be helpful. Actually, our results show that the derivation efficiency of the cell lines in the 3× aggregate group was two times higher than that of the single-embryo group ([Table 2](#t2-ajas-28-11-1565){ref-type="table"}). Therefore, the embryo-aggregation method effectively overcame the obstacles of an *in vitro* system to derive ESCs from IVF embryos. Interestingly, pESCs derived from 3× aggregated embryos at passage 16 had normal sex karyotypes. In our previous study ([@b16-ajas-28-11-1565]), porcine IVF aggregates developed into chimeric blastocysts with random cell populations in each embryo. All embryos developed equally into chimeric pig blastocysts, and no particular embryo type was predominant.

In conclusion, we observed a change from a dome-shaped morphology to a flat morphology during the early process of generating porcine embryo outgrowths. We demonstrated that aggregating four-cell-stage IVF embryos successfully supported *in vitro* development of porcine blastocysts during the pre-implantation stage and that these aggregated blastocysts formed more colonies than did their non-aggregated counterparts. We also showed that these cell lines had AP activity and expressed pluripotent markers such as Oct4, Sox2, and Nanog, The cell lines also formed EBs, revealed normal karyotypes, and were capable of differentiating into the three germ layers. This technique could be useful for therapeutic cloning, genetic engineering, and enhancing the quality of SCNT embryos.
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![Outgrowths derived from porcine blastocysts. (A) Morphology of trophectoderm (TE)-like giant cells in a blastocyst surface section. (B) Morphology of an inner cell mass (ICM)-like mass of cells inside a blastocyst. (C) Giant cells attached to feeder layer cells 3 days after blastocyst seeding. (D) The mass of cells presumed to be the ICM is attached to the feeder layer. (E) Morphology of an embryonic stem (ES)-like primary colony derived from a porcine embryo. (F) Late morphology of an ES-like primary colony derived from a porcine embryo. Scale bars = 100 μm.](ajas-28-11-1565f1){#f1-ajas-28-11-1565}

![Morphology of 1×, 2×, and 3× blastocysts. Morphology of 1× (A: right; B), 2× (A: left; C), and 3× (A: above; D) blastocysts. *In vitro-*developed blastocysts from each group were collected on day 7. This photograph was taken with a digital camera at the same scale. Scale bars = 100 μm. Abbreviations: 1×, zona-free, non-aggregated; 2×, two-embryo aggregate; 3×, three-embryo aggregate.](ajas-28-11-1565f2){#f2-ajas-28-11-1565}

![Verification of the undifferentiated state and differentiation potential of outgrowths. (A) Expression of pluripotent markers in our porcine embryonic stem (pES)-like cells. NC, water blank was used for negative control (NC). Several stem cell lines derived from various origins were used as a positive control. pESI5 and pESI6: derived from *in vitro*-fertilized embryos. pESP1 and pESP2: parthenogenetic embryos. pES11 and pES12: *in vivo*-produced embryos. (B) Primary colonies, typical morphology, and alkaline phosphatase (AP) activity in our pES-like cells, Scale bars = 200 μm. (C) Expression of the pluripotent markers Oct4, Sox2, and Nanog in pES-like cells by immunocytochemistry analysis. Scale bars = 100 μm.](ajas-28-11-1565f3){#f3-ajas-28-11-1565}

![Karyotyping and differentiation potential of porcine embryonic stem (pES)-like cells. (A) Both the pES-like cells derived from *in vitro* fertilization (IVF) and IVF aggregated blastocysts had normal karyotypes. (B) Representative embryoid bodies (EBs) derived from pES-like cells after 5 days of culture using the hanging drop method. The differentiation potential of EBs cultured on culture plates into the three germ layers from pES-like cells was confirmed. (C) Cytokeratin17 (endoderm), (D) vimentin (mesoderm), and (E) neurofilament (ectoderm). (F) Nanog was the negative control. Scale bars = 100 μm.](ajas-28-11-1565f4){#f4-ajas-28-11-1565}

###### 

Reverse transcription-polymerase chain reaction conditions and primers

  ----------------------------------------------------------------------------------------------
  Genes       Primer sequences                 Annealing temperature (°C)   Products size (bp)
  ----------- -------------------------------- ---------------------------- --------------------
  *Oct4*      5′-AACGATCAAGCAGTGACTATTCG-3′\   60                           153
              5′-GAGTACAGGGTGGTGAAGTGAGG-3′                                 

  *Nanog*     5′-AATCTTCACCAATGCCTGAG-3′\      60                           141
              5′-GGCTGTCCTGAATAAGCAGA-3′                                    

  *Sox2*      5′-CGGCGGCAGGATCGGC-3′\          60                           113
              5′-GAGCTCCGCGAGGAAAA-3′                                       

  *β-Actin*   5′-GTGGACATCAGGAAGGACCTCTA-3′\   60                           137
              5′-ATGATCTTGATCTTCATGGTGCT-3′                                 
  ----------------------------------------------------------------------------------------------

###### 

Efficiency of the porcine embryonic stem (ES)-like cell lines derived from embryos with different origins

  Embryo origins                    No. of blastocysts   ES lines (%)
  --------------------------------- -------------------- --------------
  IVF blastocysts                   120                  6 (5)
  IVF aggregated (3×) blastocysts   32                   3 (9.4)
  *In vivo* produced blastocysts    3                    2 (66.7)

IVF, *in vitro* fertilized.

###### 

Effect of embryo aggregation on the formation of *in vitro*-fertilized (IVF) blastocysts

  Embryo   No. of embryos (%)                  
  -------- -------------------- -------------- -----------------
  1× IVF   111                  n.a            52 (46.8)^a^
  2× IVF   148                  58/74 (78.4)   48/58 (82.8)^b^
  3× IVF   297                  84/99 (84.8)   71/84 (84.5)^b^

1×, zona-free, non-aggregated; 2×, two-embryo aggregate; 3×, three-embryo aggregate; n.a, not applicable.

Values with different letter superscripts within the same column are significantly different (p\<0.05).

[^1]: Both authors contributed equally to this work.
